Following The Validation Of Trial Results, BioXcel (BTAI) Stock Is Rising
Fahim Awan
October 25, 2023
BioXcel Therapeutics, Inc. (NASDAQ: BTAI) shares have exhibited a notable surge of 23.08%, reaching $2.88 in the present trading session, as per the most recent